SARA CUADRA ACREE

Allopathic & Osteopathic Physicians|Pathology|Anatomic Pathology & Clinical Pathology MARIETTA, GA NPI 1508090937

General Payments — all program years on this page

$10,175.41

  • Category: General Payments
  • Program years: PY2018–2023
  • Record count: 35
  • As of (CMS publication): 2026-01-23

Latest program year (PY2023): $5,830.04 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2023) · sorted by reported total.

By paying entity

Latest program year (PY2023) · sorted by reported total.

Paying entityAmountRecords
Teleflex LLC $4,913.048
Roche Diagnostics Corporation $900.058
Abbott Laboratories $16.951

By program year

Program yearAmountRecords
2018 $3,780.944
2019 $229.347
2020 $29.042
2021 $125.982
2022 $180.073
2023 $5,830.0417

Records — PY2023 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1019215633 Abbott Laboratories $16.95 09/04/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1027302355 Teleflex LLC $4,200.00 01/19/2023 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 View at CMS
1027302361 Teleflex LLC $77.33 01/19/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS
1027317173 Teleflex LLC $487.13 01/19/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS
1027317181 Teleflex LLC $69.92 01/19/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS
1027334573 Teleflex LLC $36.85 01/19/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS
1027351505 Teleflex LLC $6.47 01/19/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1027400317 Teleflex LLC $21.80 01/19/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS
1027417237 Teleflex LLC $13.54 01/19/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1059018651 Roche Diagnostics Corporation $302.25 07/13/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS
1059018655 Roche Diagnostics Corporation $40.00 07/13/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS
1059018659 Roche Diagnostics Corporation $36.91 08/23/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS
1059018663 Roche Diagnostics Corporation $23.12 08/17/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS
1059018667 Roche Diagnostics Corporation $127.15 08/16/2023 Food and Beverage Undisputed 01/23/2026 View at CMS
1059018671 Roche Diagnostics Corporation $23.12 08/18/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS
1059018677 Roche Diagnostics Corporation $23.12 08/18/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS
1059018683 Roche Diagnostics Corporation $324.38 08/18/2023 Travel and Lodging Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.